Al-Aqar Healthcare REIT (XKLS:5116) Growth Rank: 7 (As of Aug. 29, 2026) — 13% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:5116 Al-Aqar Healthcare REIT XKLS:5116
71 GF Score
Price RM1.16
GF Value RM1.33
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Al-Aqar Healthcare REIT Growth Rank?

Al-Aqar Healthcare REIT XKLS:5116 -0.85% 71 Growth Rank is 7 as of Aug. 29, 2026, which is 13% below its 10-year median of 8.00. GuruFocus rates XKLS:5116 with a GF Score™ of 71/100 and a GF Value™ of RM1.33 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Al-Aqar Healthcare REIT has the Growth Rank of 7.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Al-Aqar Healthcare REIT Growth Rank Related Terms


XKLS:5116 vs WELL, VTR, OHI: Growth Rank Comparison

For the REIT - Healthcare Facilities subindustry, Al-Aqar Healthcare REIT's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Al-Aqar Healthcare REIT Growth Rank vs REITs Industry

For the REITs industry and Real Estate sector, Al-Aqar Healthcare REIT's Growth Rank distribution charts can be found below:

* The bar in red indicates where Al-Aqar Healthcare REIT's Growth Rank falls into.


XKLS:5116
71GF Score
Al-Aqar Healthcare REIT XKLS:5116
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 7 mean?
Al-Aqar Healthcare REIT (XKLS:5116) has a Growth Rank of 7 as of Aug. 29, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Al-Aqar Healthcare REIT and its competitors. This is 13% below median its historical median of 8.00. Over the past decade, Al-Aqar Healthcare REIT's Growth Rank has ranged from 5.00 to 10.00.
Is Al-Aqar Healthcare REIT's Growth Rank too high?
Al-Aqar Healthcare REIT's current Growth Rank of 7 is 13% below median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 10.00. Overall, Al-Aqar Healthcare REIT has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Al-Aqar Healthcare REIT's Growth Rank compare to WELL and VTR?
Al-Aqar Healthcare REIT's Growth Rank of 7 can be compared against companies in the REITs industry. Historically, Al-Aqar Healthcare REIT's own Growth Rank has ranged from 5.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a REITs company?
A good Growth Rank depends on the REITs industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Al-Aqar Healthcare REIT and its competitors. Al-Aqar Healthcare REIT's current Growth Rank is 7, which is 13% below median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al-Aqar Healthcare REIT stock overvalued right now?
Based on GuruFocus' analysis, Al-Aqar Healthcare REIT (XKLS:5116) is currently considered Modestly Undervalued. The stock's GF Value™ is RM1.33, compared to a current price of RM1.16 — trading 12.8% below its estimated fair value. The current Growth Rank is 7, which is 13% below median its 10-year median of 8.00. Al-Aqar Healthcare REIT's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Al-Aqar Healthcare REIT (XKLS:5116), the current Growth Rank is 7 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Al-Aqar Healthcare REIT (XKLS:5116) Overvalued in 2026?

Based on GuruFocus' analysis, Al-Aqar Healthcare REIT stock appears to be undervalued. The current stock price of RM1.16 is trading 12.8% below its estimated GF Value™ of RM1.33. GuruFocus considers Al-Aqar Healthcare REIT to be Modestly Undervalued.

Key valuation signals for XKLS:5116:

  • Growth Rank: 7 (13% below median its 10-year median of 8.00)
  • GF Value™: RM1.33 vs. price of RM1.16 (12.8% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the XKLS:5116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Al-Aqar Healthcare REIT Business Description

Industry Real EstateREITs
Address Unit 1-19-02, Level 19, Block 1, V SQUARE, Jalan Utara, Petaling Jaya, SGR, MYS, 46200
Al-Aqar Healthcare REIT is engaged in investing in Syariah-compliant properties with the primary objective of providing unitholders with distribution and potential for the sustainable long-term growth of such distribution and capital appreciation. The company operates in Malaysia and Australia. The Malaysian geographic segment generates the maximum revenue for the company.
71GF Score

Get the complete analysis for XKLS:5116

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.16
Price
RM1.33
GF Value